Skip to main content
. 2022 Dec 6;58(12):1801. doi: 10.3390/medicina58121801

Table 1.

Inclusion and exclusion criteria.

Inclusion criteria

  1. Using hUCB-MSCs as a treatment for knee cartilage defects and osteoarthritis.

  2. Only direct surgical treatment of cartilage lesions using hUCB-MSCs.

  3. Randomized controlled trials (RCTs), prospective cohort studies, retrospective cohort studies, and case–control studies.

  4. Full text available, written in English.

Exclusion criteria

  1. Using hUCB-MSCs for intra-articular injection therapy.

  2. If there is no clinical outcome comparison between before and after surgery.

  3. If there is a risk of overlapping patient groups.

  4. Animal studies, phase I/II clinical trials, case reports, technical notes, review articles, and articles without accessible full-text versions.